26 results on '"Martinez Climent, Jose-Angel"'
Search Results
2. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
3. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
4. CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation
5. Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
6. PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
7. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
8. Abstract 5117: Combined treatment with the epigenetic drug CM272 and an anti-BCL-XL proapoptotic drug sensitizes solid tumors to immune checkpoint blockade
9. MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
10. Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphoma
11. Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma
12. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma
13. Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells
14. Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance
15. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
16. The Pathogenesis of Multiple Myeloma (MM) Is Preceded By Mutated Lymphopoiesis and B Cell Oligoclonality That Persist in Patients with Negative Minimal Residual Disease (MRD)
17. Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells
18. Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics
19. G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities
20. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
21. Induced Transdifferentiation of Leukemia B-Cells to Macrophages Involves Reconfiguration of the DNA Methylome
22. NIK and the Alternative NF-κB Pathway in Human Lymphomas.
23. Generation of a New Monoclonal Antibody Against MALT1 by Genetic Immunization
24. Identification and Characterization of Single Nucleotide Polymorphisms (SNPs) Associated with Genetic Predisposition to Develop Therapy-Related Acute Myeloid Leukemia (t-AML).
25. MALT1is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
26. Preneoplastic somatic mutations including MYD88(L265P) in lymphoplasmacytic lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.